
zzso agents zzso have been shown to reduce the need for red blood cell zzso zzso and to improve quality of life for cancer patients with zzso However, increased risks of mortality and disease progression have been reported when using zzso with excessive target zzso zzso In 2007, the United States Food and Drug Administration and Korea Food and Drug Administration issued regulatory alerts for using zzso in cancer zzso 

This retrospective study was performed to evaluate changes in zzso prescribing patterns between 2006 and 2010 and the impact on zzso zzso in patients with solid zzso 

The Seoul National University Hospital zzso in zzso 

This study includes adult patients with solid zzso who were diagnosed and treated in the zzso from January 2006 to December zzso The exclusion criterion was zzso chronic zzso zzso The patients' zzso levels and prescription data for zzso and zzso zzso were statistically zzso The number of zzso and zzso zzso patients was also zzso as a zzso Main outcome measure Prescription data on zzso and zzso zzso 

After adjusting for the number of patient visits, the monthly mean zzso doses dispensed decreased by an average of zzso zzso per quarter over the last 5 years, and the number of zzso zzso ordered increased by zzso instances per zzso After correcting for the number of patients, the mean doses of zzso dispensed each month decreased by zzso zzso per quarter, and the number of zzso zzso ordered increased by zzso instances per zzso 

During the last 5 years, the number of zzso doses dispensed at zzso decreased and the number of zzso zzso at zzso increased, independent of the number of zzso The reduction in zzso use was thought to be due to the release of the safety alert letter in zzso However, this study did not zzso other risk factors that may have influenced the number of zzso zzso zzso zzso cancer, zzso zzso Still, the results of this study suggest that the decreased zzso doses were relevant to the increased zzso zzso 

